część 1
This tender has been awarded
Awarded to ASCLEPIOS S.A.; Farmacol-Logistyka sp. z o.o.; Urtica Sp. z o. o.; Takeda Pharma Sp. z o. o.; Bialmed Sp. z o.o. — PLN 21,892,825
About This Opportunity
część 1 — supply contract awarded in Poland by Szpital Uniwersytecki W Krakowie. Awarded to ASCLEPIOS S.A.; Farmacol-Logistyka (PLN 21.9M, Feb 2026).
This is a supplies contract in the health and medical services sector, with a focus on Medical Equipment and Pharmaceuticals. Located in Poland, Europe, this opportunity is open to firms and consortiums, with an estimated budget of PLN 27,300.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
This tender, designated as "część 1" (Part 1), is issued by a contracting authority in Poland and originates from the TED (Tenders Electronic Daily) database, serving the European Union's public procurement market. The procurement seeks the supply of pharmaceutical products, specifically Temsirolimusum, in a quantity of 40 units of packaging.
This is a goods procurement tender focused on essential medical supplies. Temsirolimusum is a well-established active pharmaceutical ingredient used in oncology treatments. Potential bidders are expected to be manufacturers or authorized distributors with the capacity to supply high-quality pharmaceutical products meeting stringent regulatory standards.
Typical requirements for such a tender would include detailed product specifications, adherence to Good Manufacturing Practices (GMP) and relevant pharmacopoeial standards, and robust quality assurance systems. Bidders will likely need to provide documentation demonstrating their legal and financial standing, as well as proof of their ability to meet the specified delivery timelines and quantities. Furthermore, compliance with EU and national pharmaceutical regulations, including potential import and distribution licenses, will be a critical consideration. The contracting authority will be looking for competitive pricing alongside a proven track record of reliability and quality in pharmaceutical supply.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 10, 2026. Last refreshed 50 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About SZPITAL UNIWERSYTECKI W KRAKOWIE
SZPITAL UNIWERSYTECKI W KRAKOWIE has issued 245 procurement notices on BidsFactory, including 35 currently open and 100 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: June 19, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
ASCLEPIOS S.A.; Farmacol-Logistyka sp. z o.o.; Urtica Sp. z o. o.; Takeda Pharma Sp. z o. o.; Bialmed Sp. z o.o. was awarded the contract for PLN 21,892,825. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to ASCLEPIOS S.A.; Farmacol-Logistyka sp. z o.o.; Urtica Sp. z o. o.; Takeda Pharma Sp. z o. o.; Bialmed Sp. z o.o.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by SZPITAL UNIWERSYTECKI W KRAKOWIE in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.